Douglas C. Bauer mainly investigates Internal medicine, Osteoporosis, Surgery, Bone density and Prospective cohort study. His Internal medicine course of study focuses on Endocrinology and Parathyroid hormone. Douglas C. Bauer has researched Osteoporosis in several fields, including Physical therapy and Bone remodeling.
His research integrates issues of Odds ratio, Alendronic acid, Lower risk, Adverse effect and Placebo in his study of Surgery. His work investigates the relationship between Alendronic acid and topics such as Randomized controlled trial that intersect with problems in Discontinuation. Douglas C. Bauer combines subjects such as Cross-sectional study, Subclinical infection and Women's Health Initiative with his study of Prospective cohort study.
Douglas C. Bauer spends much of his time researching Internal medicine, Osteoporosis, Endocrinology, Prospective cohort study and Surgery. In most of his Osteoporosis studies, his work intersects topics such as Physical therapy. His Thyroid function tests, Estrogen and Vitamin D and neurology study in the realm of Endocrinology interacts with subjects such as Context.
His Prospective cohort study research incorporates elements of Incidence, Cohort study, Epidemiology, Gynecology and Pediatrics. His studies in Surgery integrate themes in fields like Odds ratio, Relative risk, Placebo and Risk factor. His work deals with themes such as Alendronic acid and Urology, which intersect with Placebo.
His scientific interests lie mostly in Internal medicine, Osteoporosis, Bone mineral, Subclinical infection and Randomized controlled trial. His Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology. His Osteoporosis research is multidisciplinary, incorporating elements of Orthopedic surgery and Physical therapy.
His Bone mineral study incorporates themes from Oncology, Reduction, Dentistry and Femoral neck. His work carried out in the field of Subclinical infection brings together such families of science as Meta-analysis, Thyroid disease, Thyroid and Cardiology. His Randomized controlled trial research is multidisciplinary, incorporating perspectives in Placebo, Quality of life and Clinical trial.
Douglas C. Bauer mostly deals with Internal medicine, Osteoporosis, Placebo, Subclinical infection and Randomized controlled trial. The study incorporates disciplines such as Endocrinology and Physiology in addition to Internal medicine. Douglas C. Bauer interconnects Surgery, N-terminal telopeptide and Bone remodeling in the investigation of issues within Osteoporosis.
The various areas that Douglas C. Bauer examines in his Placebo study include Relative risk, Quality of life and Urology. The Randomized controlled trial study combines topics in areas such as Levothyroxine, Physical therapy, Gastroenterology and Body mass index. Douglas C. Bauer has included themes like Bone mineral, Bone density and Surrogate endpoint in his Femoral neck study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
Dennis M Black;Steven R Cummings;David B Karpf;Jane A Cauley.
The Lancet (1996)
Primer on the metabolic bone diseases and disorders of mineral metabolism
John P. Bilezikian;Roger Bouillon;Thomas Clemens;Juliet Compston.
Rhode Island dental journal (2013)
Effects of Continuing or Stopping Alendronate After 5 Years of Treatment The Fracture Intervention Trial Long-term Extension (FLEX): A Randomized Trial
Dennis M. Black;Ann V. Schwartz;Kristine E. Ensrud;Jane A. Cauley.
Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults.
Kim Sutton-Tyrrell;Samer S. Najjar;Robert M. Boudreau;Lakshmi Venkitachalam.
Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial
Dennis M. Black;Desmond E. Thompson;Douglas C. Bauer;Kris Ensrud.
The Journal of Clinical Endocrinology and Metabolism (2000)
Subclinical hypothyroidism and the risk of coronary heart disease and mortality.
Nicolas Rodondi;Wendy P. J. den Elzen;Douglas C. Bauer;Anne R. Cappola.
Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study.
Matteo Cesari;Stephen B. Kritchevsky;Brenda W. H. J. Penninx;Barbara J. Nicklas.
Journal of the American Geriatrics Society (2005)
Broadband Ultrasound Attenuation Predicts Fractures Strongly and Independently of Densitometry in Older Women: A Prospective Study
Douglas C. Bauer;Claus C. Glüer;Jane A. Cauley;Thomas M. Vogt.
JAMA Internal Medicine (1997)
Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group.
Bauer Dc;Glüer Cc;Cauley Ja;Vogt Tm.
JAMA Internal Medicine (1997)
Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women
Steven R. Cummings;Warren S. Browner;Douglas Bauer;Katie Stone.
The New England Journal of Medicine (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: